Position in ALMS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$10,982,141
+$6,765,798 QoQ
Shares Held
390,268
+103.9% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
8.20%
of 13F equity value
Holder Rank
#41
of 198 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trium Capital LLP holds $12,505,730 across 2 Biotechnology names. ALMS ranks #1 (87.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALMS |
Alumis Inc.
This page
|
390,268 | $10,982,141 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
|
113,278 | $1,523,589 |
All Filings in ALMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,982,141 | 390,268 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,216,343 | 191,391 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $8,716,724 | 893,107 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $12,457,222 | 3,122,111 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $7,944,117 | 2,648,039 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||